Disc Medicine shareholders elect directors, ratify auditor at 2023 annual meeting

Proposal 2 – Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the stockholders’ vote with respect to such ratification were as follows: Votes For Votes Against Abstain 13,678,267 18,084 373,951

Proposal 1 - Election of Class II and Class III Director Nominees The stockholders of the Company elected Georges Gemayel, Ph.D., Mark Chin, MS, MBA, and Liam Ratcliffe, M.D., Ph.D. as Class II directors of the Company, for a two-year term ending at the annual meeting of stockholders to be held in 2025 and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal. The results of the stockholders’ vote with respect to the election of the Class II directors were as follows: Name Votes For Votes Withheld Broker Non-Votes Georges Gemayel, Ph.D. 13,073,343 16,929 980,030 Mark Chin, MS, MBA 13,073,267 17,005 980,030 Liam Ratcliffe, M.D., Ph.D. 13,081,593 8,679 980,030 The stockholders of the Company elected Donald Nicholson, Ph.D., William White, MPP, J.D., and John Quisel, J.D., Ph.D. as Class III directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2026 and until their successors h